SCHEMBL3637360

SCHEMBL3637360

Nc1ccc(Cl)cc1C(=O)NO

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 3/20 0.61
RECQL P46063 1/20 0.54
GCK P35557 2/20 0.54
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ABL1 P00519 1/20 0.47
NOS2 P35228 2/20 0.47
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44
KDR P35968 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3960903 0.85 ABL1 (0.61) FADS1RECQLALDH1A1KDM4ENPC1
SCHEMBL1095186 0.85 ALDH1A1 (0.70) FADS1RECQLGCKALDH1A1KDM4E
SCHEMBL140037 0.83 FADS1 (0.59) FADS1RECQLGCKALDH1A1KDM4E
SCHEMBL8208503 0.80 FADS1 (0.56) FADS1RECQLGCKALDH1A1KDM4E
SCHEMBL6587131 0.80 FADS1 (0.74) FADS1GCKALDH1A1HDAC1
SCHEMBL14215697 0.80 MAPT (0.59) FADS1RECQLALDH1A1KDM4ENPC1
SCHEMBL9540049 0.79 RECQL (0.79) FADS1RECQLGCKALDH1A1KDM4E
SCHEMBL11689255 0.79 NOS2 (0.63) FADS1RECQLGCKALDH1A1ABL1
SCHEMBL13761455 0.79 FADS1 (0.55) FADS1RECQLGCKALDH1A1KDM4E
SCHEMBL4339605 0.79 FADS1 (0.55) FADS1RECQLGCKALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524898-B2 Proton acceptor iminium/carbocation-type coupling agents LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2013-09-03 US disclosed
US-8524898-B2 Proton acceptor iminium/carbocation-type coupling agents LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2013-09-03 US disclosed
US-20100144588-A1 PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2010-06-10 US disclosed
US-20100144588-A1 PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2010-06-10 US disclosed
EP-2170822-A2 PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS Luxembourg Bio Technologies Ltd. (IL) 2010-04-07 EP disclosed
WO-2009138985-A2 COUPLING AGENTS FOR THE SYNTHESIS OF POLYPEPTIDES AND POLYNUCLEOTIDES LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2009-11-19 WO disclosed
WO-2009138985-A2 COUPLING AGENTS FOR THE SYNTHESIS OF POLYPEPTIDES AND POLYNUCLEOTIDES LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2009-11-19 WO disclosed
WO-2008139481-A2 PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2008-11-20 WO disclosed
WO-2008139481-A2 PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS LUXEMBOURG BIO TECHNOLOGIES LTD. (IL) 2008-11-20 WO disclosed
US-6429311-B2 CHEMICAL INTERMEDIATE FOR HYPOTENSIVE AGENTS, BACTERICIDES, FUNGICIDES, ANTIPYRETICS AND ANTIDEPRESSANTS SEPRACOR INC. 2002-08-06 US disclosed
US-20010018518-A1 Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof GAO YUN (US) 2001-08-30 US disclosed
US-6184377-B1 ANTIPYRETIC, HYPOTENSIVE, ANTIBACTERIAL, ANTIFUNGAL OR CENTRAL NERVOUS SYSTEM (CNS) ACTIVITY, AS WELL AS THE ABILITY TO INHIBIT ENZYMES SEPRACOR INC. 2001-02-06 US disclosed
EP-0174412-B1 STABILISATION OF THERMOPLASTICS CONTAINING CHLORINE WITH ORGANIC COMPOUNDS CONTAINING NITROGEN CIBA-GEIGY AG (CH) 1988-10-26 EP disclosed
US-4642322-A Stabilization of chlorine-containing thermoplastics with nitrogen-containing organic compounds CIBA-GEIGY CORPORATION (US) 1987-02-10 US disclosed
WO-1986001812-A1 STABILIZER OF CHLORINE-CONTAINING THERMOPLASTS WITH NITROGEN-CONTAINING ORGANIC COMPOUNDS CIBA-GEIGY AG (CH) 1986-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144588-A1 PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS PHAX, GIPR, IAPP FADS1 4228/4885RECQL 800/4885GCK 1244/4885
US-20010018518-A1 Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof NQO2, ASNS, AAAS FADS1 395/4885RECQL 476/4885GCK 1734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.